Despite its importance, freshwater is a scarce resource, with only 2.5% of Earth’s water being freshwater and 0.3% of that available for human use. Freshwater risk is commonly viewed through a humanitarian or public health lens. Its scarcity underpins many risks, including waterborne illnesses, supply issues, and social inequality. Calvert believes ensuring just access to freshwater promotes social equality, enhances quality of life, and lays the foundation for sustainable development. Yet, the critical risks that threaten sustainable development, as well as pressing economic concern associated with this finite resource, are often overlooked. These risks are often neglected since freshwater resources may be mistakenly considered affordable and abundant.
Key Takeaways
Calvert has one of the industry's largest and most diverse teams of ESG professionals, spanning research, engagement and investment solutions.
Risk Considerations:
Investing involves risk including the risk of loss. There is no guarantee that any investment strategy, including those with an ESG focus, will work under all market conditions. Investors should evaluate their ability to invest for the long-term, especially during periods of downturn in the market.
Prior to making any investment decision, investors should carefully review the strategy’s relevant offering document. For the complete content and important disclosures, refer to the PDF.
Morgan Stanley Investment Management (Australia) Pty Limited operates under AFSL No: 314182.
Not to be shown, quoted or distributed to the public. The information shown in this website is not personal advice and does not take into account the investment objectives, financial situation or needs of any person.
Information on this website should not be considered a solicitation to buy, an offer to sell or a recommendation for any security in any jurisdiction where such an offer, solicitation or recommendation would be unlawful or unauthorized. In addition, investments may not be made via this website.
Past performance of any product described on this site is not a reliable indication of future performance.
© 2026 Morgan Stanley | Investment Management (Australia) Pty Limited ACN 122040037